Drospirenone clinical trials
How each study uses drospirenone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the drospirenone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 11 May 2001 · YASMIN · NDA 021098 (FDA, Drugs@FDA; in a combination)
- European Union
- 19 May 2021 · Drovelis · EMEA/H/C/005336 (EMA; in a combination)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
33 studies that test it; most in 2007 (4)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 4 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 4 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 19 · Other 14
Estetra (6) · Bayer (6) · Massachusetts General Hospital (3) · Insud Pharma (2) · Chulalongkorn University (2) · NewAmsterdam Pharma (1) · Eli Lilly and Company (1) · University of Palermo (1)
Often tested with
Tested in the same studies.
Ethinyl Estradiol (12) · Estetrol (8) · Estradiol (8) · Dienogest (2) · TA-8995 (1) · Retatrutide (1) · Nomegestrol acetate (1) · Norgestimate (1)
Related medicines
As reviewed, each with the page that says it.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test drospirenone.
- Dec 2026A Randomized Feasibility Trial Comparing Drospirenone and Norethindrone for Postpartum Hypertension Management in PreeclampsiaPhase 4 · Oregon Health and Science University
- Jul 2027Estetrol/Drospirenone to Reduce the Average Size of EndometriomasPhase 4 · Andrew Zakhari
Studies
Open first, then newest update. How each study uses drospirenone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 33
- Estetrol/Drospirenone to Reduce the Average Size of EndometriomasRecruitingPhase 4Andrew ZakhariNCT05837624Written as Estetrol/Drospirenone
- A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced MalignanciesRecruitingPhase 1Novartis PharmaceuticalsNCT07340190Written as drospirenone
- Pharmacokinetics of Drospirenone Only Pills: A Pre- and Post-Bariatric Surgery StudyRecruitingPhase 1/2Chulalongkorn UniversityNCT06345560Written as Drospirenone
- Drospirenone Only Pills and Cervical Mucus Changes: A Pre- and Post-Bariatric Surgery StudyRecruitingNot applicableChulalongkorn UniversityNCT06345586Written as Drospirenone
- A Randomized Feasibility Trial Comparing Drospirenone and Norethindrone for Postpartum Hypertension Management in PreeclampsiaNot yet recruitingPhase 4Oregon Health and Science UniversityNCT07293728Written as Drospirenone
- LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult WomenActive, not recruitingPhase 4Insud PharmaNCT05303636Written as drospirenone 4 mg oral tablet or drospirenone 3.5 mg chewable tablet
- Efficacy, Safety, and Tolerability of LPRI-CF113 as an Oral Contraceptive in FemalesCompletedPhase 3Insud PharmaNCT05461573Written as Drospirenone
- Evaluate the Pharmacokinetics of a Combined Oral Contraceptive (COC) With and Without ObicetrapibCompletedPhase 1NewAmsterdam PharmaNCT06250205Written as Obicetrapib + Drospirenone / Ethinyl Estradiol (COC)
- A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or ObeseCompletedPhase 1Eli Lilly and CompanyNCT06039826Written as Drospirenone
- The Use of Drospirenone/Estetrol, Nomegestrol Acetate/Estradiol and Ethinylestradiol/Dienogest in Random Start Rapid Endometrial PreparationCompletedPhase 4University of PalermoNCT06324851Written as Drospirenone / Estetrol
- E4/DRSP Ovarian Function Inhibition StudyCompletedPhase 2EstetraNCT03091595Written as 15 mg E4/3 mg DRSP
- Effect of Two Different Dosages of Ethinyl-estradiol in Association With Drospirenone in Women With Polycystic Ovary Syndrome.CompletedNot applicableCatholic University of the Sacred HeartNCT01519401Written as 3 mg drospirenone and 20 µg ethinyl-estradiol
- E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - United States/Canada StudyCompletedPhase 3EstetraNCT02817841Written as 15 mg E4/3 mg DRSP
- E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - EU/Russia StudyCompletedPhase 3EstetraNCT02817828Written as 15 mg E4/3 mg DRSP
- Safety, Efficacy, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 CyclesCompletedPhase 3Laboratories Leon Farma, S.A.NCT02269241Written as LF111 (drospirenone)
- Study to Evaluate Cycle Control With Norgestimate/Ethinyl Estradiol and Drospirenone/Ethinyl Estradiol in Healthy Sexually Active FemalesCompletedPhase 4Ortho-McNeil Janssen Scientific Affairs, LLCNCT00745901Written as Norgestimate/ethinyl estradiol; Drospirenone/ethinyl estradiol
- Estetrol (E4)/Drospirenone (DRSP) Drug-drug Interaction (DDI) StudyCompletedPhase 1EstetraNCT03512860Written as E4/DRSP
- "E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"CompletedPhase 1/2EstetraNCT02957630Written as 15 mg E4/3 mg DRSP
- Treatment Choice in Primary DysmenorrheaCompletedPhase 4Adana Numune Training and Research HospitalNCT03124524Written as ethinylestradiol and drospirenone
- The Oral Contraceptive Pill for Premenstrual Worsening of DepressionCompletedNot applicableMassachusetts General HospitalNCT00633360Written as Drospirenone and ethinyl estradiol
See all 33 studies that test drospirenone →
Given beside what is tested · 22 — drospirenone is usual care or a partner of the new treatment
- Effects of VX-407 on the Pharmacokinetics of Combined Oral ContraceptivesRecruitingPhase 1Vertex Pharmaceuticals IncorporatedNCT07792408Written as DRSP/EE
- A Drug-drug Interaction Study of Vorasidenib and a Combined Oral Contraceptive in Healthy Female ParticipantsCompletedPhase 1Institut de Recherches Internationales Servier (I.R.I.S.)NCT07235774Written as DRSP/EE
- Effects of VX-407 on the Pharmacokinetics of Oral Contraceptives in Healthy ParticipantsCompletedPhase 1Vertex Pharmaceuticals IncorporatedNCT07074327Written as DRSP/EE
- A Drug-Drug Interaction Study Between HS-10374 Tablets and Drospirenone and Ethinyl Estradiol Tablets(Yasmin®)CompletedPhase 1Hansoh BioMedical R&D CompanyNCT07181343Written as Drospirenone and Ethinyl Estradiol tablets
- Evaluation of the Effect of Suzetrigine (SUZ) on the Pharmacokinetics of Oral Contraceptives in Healthy Female ParticipantsCompletedPhase 1Vertex Pharmaceuticals IncorporatedNCT06820307Written as DRSP/EE
- A Study of Milvexian in Healthy Adult FemalesCompletedPhase 1Janssen Pharmaceutica N.V., BelgiumNCT05706753Written as Drospirenone
- Efficacy and Safety of Dingkundan Combined With Combination Oral Contraceptives in the Treatment of PCOSCompletedNot applicableGuangdong Women and Children HospitalNCT05872425Written as Drospirenone and Ethinylestradiol Tablets (Ⅱ)
- Study in Women on the Effect of JNJ-64530440 on Oral Contraceptive and Midazolam, and the Effect of a High-fat Meal on JNJ-64530440WithdrawnPhase 1Janssen Research & Development, LLCNCT03890341Written as Drospirenone/Ethinylestradiol
- Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and MidazolamCompletedPhase 1BayerNCT03353857Written as Drospirenone, Ethinylestradiol/ Yasmin
- YAZ Post Authorization Safety Study (PASS)/Post Authorization Efficacy Study (PAES) in ChinaCompletedPhase 4BayerNCT02710708Written as EE20/DRSP (YAZ, BAY86-5300)
- A Study in Healthy Female Participants to Investigate the Effect of JNJ-56136379 at Steady-state on the Single-dose Pharmacokinetics of Ethinylestradiol and Drospirenone (Oral Contraceptive) and on the Single-dose Pharmacokinetics of Midazolam (Probe Substrate for Cytochrome P450 3A4)CompletedPhase 1Janssen Sciences Ireland UCNCT03111511Written as Drospirenone/Ethinylestradiol
- Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral ContraceptivesTerminatedPhase 2National Institute of Mental Health (NIMH)NCT00089414Written as Ethinyl Estradiol/Drospirenone
- To Evaluate the Effects of Odalasvir and AL-335 With Simeprevir on the Single-Dose Pharmacokinetics of Ethinylestradiol and Drospirenone in Healthy Female ParticipantsCompletedPhase 1Janssen Research & Development, LLCNCT02885454Written as Drospirenone/ethinylestradiol
- Study of Treatment With the Combination of Drospirenone Plus Ethinyl Estradiol Plus Levomefolate Calcium in Mexican Women Seeking ContraceptionCompletedPhase 3BayerNCT01902264Written as EE20/DRSP/L-5-MTHF (Beyaz, BAY98-7071)
- Comparative Study of BAY86-5300 With an Extended Flexible Regimen for EndometriosisCompletedPhase 3BayerNCT01697111Written as EE20/DRSP(BAY86-5300)
- To Investigate Efficacy of YAZ in the Treatment of DysmenorrheaWithdrawnPhase 3BayerNCT02617537Written as EE20/DRSP(YAZ,BAY86-5300)
- Comparative Study of BAY86-5300 With a Flexible Extended Regimen for DysmenorrheaCompletedPhase 3BayerNCT01892904Written as EE20/DRSP(BAY86-5300)
- GA YAZ ACNE in China Phase IIICompletedPhase 3BayerNCT00818519Written as EE20/Drospirenone (YAZ, BAY86-5300)
- Comparative Trial in Hormone Withdrawal Associated SymptomsCompletedPhase 3BayerNCT01076582Written as EE20/DRSP (YAZ, BAY86-5300)
- Clinical Study of a Conventional and Flexible Extended Oral Contraceptive of EE/DRSP With or Without Metafolin in Latin AmericaWithdrawnPhase 3BayerNCT01331655Written as EE20/DRSP (BAY86-5300)
Showing 20 of 22.
As the comparator · 5 — what is tested is compared with drospirenone
- A Study to Evaluate the Effectiveness of NuvaRing® to Prevent Pregnancies in Chinese Women (P06450)CompletedPhase 3Organon and CoNCT01277211Written as DRSP 3 mg + EE 30 µg
- LCS16 vs. COC User Satisfaction and Tolerability StudyCompletedPhase 3BayerNCT03074045Written as Ethinyl estradiol and drospirenone (Yarina, BAY86-5131)
- E4/DRSP Single and Multiple Dose PK and Early QT StudyCompletedPhase 1EstetraNCT02874248Written as 15 mg E4/3 mg DRSP
- Efficacy and Safety Study for an Oral Contraceptive Containing FolateCompletedPhase 3BayerNCT00468481Written as Drospirenone/Ethinylestradiol (Yaz)
- Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZCompletedPhase 3BayerNCT00567164Written as EE20/DRSP (BAY86-5300)
Codes
What other systems call drospirenone · ClinicalTrials.gg INT003045
- MeSH (NLM) C035144drospirenoneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) N295J34A25DROSPIRENONEConfirmed FDA, NLM, Wikidata
- RxNorm 11636Confirmed FDA, Wikidata
- Wikidata Q419646drospirenoneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47502DrospirenoneOne source FDA
- DrugBank DB01395One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C035144 | drospirenone | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | N295J34A25 | DROSPIRENONE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 11636 | — | Confirmed FDA, Wikidata |
| Wikidata | Q419646 | drospirenone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47502 | Drospirenone | One source FDA |
| DrugBank | DB01395 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.